Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 29446K106 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Affinity Asset Advisors, LLC
13G
|
6.5% |
8/13/2026
Event 6/30/2026
|
|
| Affinity Asset Advisors, LLC | 6.5% | ||
| Michael Cho | 6.5% | ||
|
Adage Capital Management, L.P.
13G/A
Amendment 1
|
7.3% |
8/12/2026
Event 6/30/2026
|
|
| Adage Capital Management, L.P. | 7.3% | ||
| Robert Atchinson | 7.3% | ||
| Phillip Gross | 7.3% | ||
|
Decheng Capital Management IV (Cayman), LLC
13G/A
Amendment 2
|
8.9% |
5/15/2026
Event 3/31/2026
|
|
| Decheng Capital Management IV (Cayman), LLC | 6.7% | ||
| Decheng Capital Global Life Sciences Fund IV, L.P. | 6.7% | ||
| Decheng Capital Global Healthcare Fund (Master), LP | 2.3% | ||
| Decheng Capital Global Healthcare GP, LLC | 2.3% | ||
| Xiangmin Cui | 8.9% | ||
|
ADAR1 Capital Management, LLC
13G/A
Amendment 1
|
9.9% |
5/15/2026
Event 3/31/2026
|
|
| ADAR1 Capital Management, LLC | 9.9% | ||
| ADAR1 Capital Management GP, LLC | 9.5% | ||
| Daniel Schneeberger | 9.9% | ||
|
Aberdeen Group plc
13G
|
5.3% |
5/7/2026
Event 4/1/2026
|
|
| Aberdeen Group plc | 5.3% | ||
| abrdn Inc. | 5.3% | ||
|
RA Capital Management, L.P.
13G
|
9.9% |
3/20/2026
Event 3/13/2026
|
|
| RA Capital Management, L.P. | 9.9% | ||
| Peter Kolchinsky | 9.9% | ||
| Rajeev Shah | 9.9% | ||
| RA Capital Healthcare Fund, L.P. | 9.9% | ||
| Janus Henderson Group PLC 13G/A Amendment 1 | 10.0% |
2/6/2026
Event 1/30/2026
|
|
| Janus Henderson Group PLC 13G | 10.0% |
12/8/2025
Event 11/28/2025
|
|
|
ADAR1 Capital Management, LLC
13G
|
9.9% |
11/14/2025
Event 9/30/2025
|
|
| ADAR1 Capital Management, LLC | 9.9% | ||
| ADAR1 Capital Management GP, LLC | 9.9% | ||
| Daniel Schneeberger | 9.9% | ||
| Woodline Partners LP 13G | 5.9% |
11/14/2025
Event 9/30/2025
|
|
|
Adage Capital Management, L.P.
13G
|
10.0% |
11/13/2025
Event 9/30/2025
|
|
| Adage Capital Management, L.P. | 10.0% | ||
| Robert Atchinson | 10.0% | ||
| Phillip Gross | 10.0% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q2 | 66 | 41.7 M | $133 M |
| 2026 Q1 | 53 | 40.5 M | $81.0 M |
| 2025 Q4 | 41 | 35.3 M | $54.7 M |
| 2025 Q3 | 43 | 29.7 M | $42.4 M |
| 2025 Q2 | 28 | 8.71 M | $2.74 M |
| 2025 Q1 | 27 | 8.66 M | $3.39 M |
| 2024 Q4 | 27 | 8.71 M | $6.52 M |
| 2024 Q3 | 28 | 8.72 M | $7.25 M |
| 2024 Q2 | 30 | 8.99 M | $6.22 M |
| 2024 Q1 | 35 | 9.04 M | $20.9 M |
| 2023 Q4 | 29 | 9.83 M | $7.10 M |
| 2023 Q3 | 29 | 9.12 M | $6.75 M |
| 2023 Q2 | 30 | 9.92 M | $7.44 M |
| 2023 Q1 | 30 | 10.8 M | $7.86 M |
| 2022 Q4 | 37 | 12.3 M | $13.4 M |
| 2022 Q3 | 35 | 12.9 M | $28.4 M |
| 2022 Q2 | 27 | 12.6 M | $25.6 M |
| 2022 Q1 | 31 | 12.7 M | $39.7 M |
| 2021 Q4 | 28 | 7.19 M | $27.0 M |
| 2021 Q3 | 23 | 7.32 M | $49.9 M |
| 2021 Q2 | 29 | 7.11 M | $41.9 M |
| 2021 Q1 | 34 | 7.63 M | $54.6 M |
| 2020 Q4 | 42 | 6.92 M | $37.0 M |
| 2020 Q3 | 36 | 7.70 M | $44.4 M |
| 2020 Q2 | 23 | 3.59 M | $10.6 M |
| 2020 Q1 | 20 | 6.29 M | $17.0 M |
| 2019 Q4 | 23 | 4.17 M | $14.1 M |
| 2019 Q3 | 22 | 4.30 M | $16.3 M |
| 2019 Q2 | 26 | 4.33 M | $24.5 M |
| 2019 Q1 | 33 | 4.55 M | $36.4 M |
| 2018 Q4 | 32 | 4.56 M | $37.2 M |